https://www.ndtvprofit.com/business/aurobindo-pharmas-stock-extends-gains-as-jpmorgan-sees-possible-re-rating?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The Hyderabad-based drugmaker’s stock rose as much as 2.7% to Rs 1,014, just shy of its all-time high, with high trading volume.